November 2008
Vol. 18 No. 11 |
| ICAAC/IDSA Symposium Highlights Alternatives to Vancomycin |
|
Vancomycin — usually used as a drug of last resort to treat infections caused by gram-positive bacteria — is increasingly being replaced by other agents because of the emergence of vancomycin-resistant organisms. Speakers at the 48th Annual ICAAC/ IDSA 46th Annual Meeting last month in
Washington,
D.C., talked about newer and investigational alternative agents, which may be used alone or in combination with vancomycin.
|
| New ARVs Offer Virologic Suppression in Most Patients |
|
Newer antiretroviral (ARV) drugs in existing and novel classes are highly effective in treatment-experienced patients, but physicians must be careful to screen adequately for resistance patterns and sensitivity to agents, according to a session on state-of-the-art HIV care at the 48th Annual ICAAC/IDSA 46th Annual Meeting.
|
|
|
|
|
